1. (1) The board hereby approves the following drugs for the use in ocular treatment limited to the anterior segment of the eye and adnexa:

   1. (a) anti-infective agents, including:

      1. (i) antibiotic;
      2. (ii) antiviral;
      3. (iii) antifungal; and
      4. (iv) antiparasitic;

   2. (b) autoimmune agents, including:

      1. (i) antiallergy;
      2. (ii) antihistamines;
      3. (iii) decongestants;
      4. (iv) mast cell stabilizers; and
      5. (v) antianaphylaxis;
   3. (c) analgesics;
   4. (d) anti-inflammatory agents;
   5. (e) antiglaucoma agents;
   6. (f) hyperosmotic agents;
   7. (g) autonomic agents; and
   8. (h) over the counter agents.

Authorizing statute(s): 37-1-131, 37-10-202, MCA

Implementing statute(s): 37-10-101, 37-10-103, 37-10-304, MCA

History: NEW, 1987 MAR p. 2234, Eff. 12/11/87; AMD, 1990 MAR p. 2176, Eff. 12/14/90; AMD, 1994 MAR p. 153, Eff. 1/28/94; AMD, 1999 MAR p. 2760, Eff. 12/3/99; TRANS, from Commerce, 2003 MAR p. 2083; AMD, 2007 MAR p. 296, Eff. 3/9/07.